|
Eris Lifesciences Ltd.
|
Cash Flow
|
|
|
You can view the
Cash Flow
for the last 5 years.
|
Market Cap. (Rs.)
|
21416.02 Cr.
|
P/BV
|
7.73
|
Book Value (Rs.)
|
203.46
|
|
52 Week High/Low (Rs.)
|
1910/1097
|
FV/ML
|
1/1
|
P/E(X)
|
60.87
|
|
Bookclosure
|
13/02/2025
|
EPS (Rs.)
|
25.83
|
Div Yield (%)
|
0.47
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| | | | | | |
| Net Profit/Loss Before Extraordinary Items And Tax | 488.87 | 431.24 | 404.64 | 442.20 | 394.50 |
| | | | | | |
| Net CashFlow From Operating Activities | 1065.01 | 486.01 | 291.74 | 378.26 | 375.36 |
| Net Cash Used In Investing Activities | -79.97 | -1854.52 | -982.10 | -319.61 | -323.36 |
| Net Cash Used From Financing Activities | -881.32 | 1379.78 | 688.03 | -44.70 | -82.40 |
| Adjustments On Amalgamation / Merger / Demerger And Others | 1.77 | 0.00 | 7.49 | 0.00 | 0.00 |
| | | | | | |
| Net Inc/Dec In Cash And Cash Equivalents | 105.49 | 11.26 | 5.15 | 13.96 | -30.39 |
| Cash And Cash Equivalents Begin of Year | 94.25 | 82.98 | 50.87 | 36.92 | 67.31 |
| Cash And Cash Equivalents End Of Year | 199.74 | 94.25 | 56.02 | 50.87 | 36.92 |
